Ali Tehrani is CEO at Zymeworks Inc. (ZYME). They have made 7 open-market trades across 1 company since 2019, most recently 2021-07-16.
CIK 0001761853
1 open-market purchase totalling $19K since 2020, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZYME | 301,516 | $8.7M |
Shares reported on the most recent Form 4, priced at the 2021-07-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZYME | SELL | 2021-07-15 | 2021-07-16 | $36.00 | $1.6M | -2.8% | -8.3% | -29.1% |
| ZYME | SELL | 2021-07-12 | 2021-07-13 | $36.12 | $915K | +1.3% | -11.2% | -26.7% |
| ZYME | SELL | 2021-03-10 | 2021-03-12 | $34.95 | $307K | -10.4% | -19.6% | +6.2% |
| ZYME | SELL | 2020-12-07 | 2020-12-09 | $56.16 | $48K | +0.0% | +8.1% | -34.3% |
| ZYME | SELL | 2020-11-02 | 2020-11-04 | $39.04 | $137K | -3.2% | +27.9% | -11.6% |
| ZYME | BUY | 2020-04-03 | 2020-04-07 | $33.39 | $19K | +8.7% | +5.2% | +2.0% |
| ZYME | SELL | 2019-03-29 | 2019-03-29 | $16.24 | $49K | -3.6% | +12.0% | +35.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.